School of Medicine Medical Course
横浜市立大学放射線医学
http://www-user.yokohama-cu.ac.jp/~radiolog/
Updated on 2025/08/01
博士(医学) ( 横浜市立大学 )
Radiation Therapy
Particle Therapy
Stereotactic Radiosurgery
High-Precision Radiation Therapy
放射線腫瘍学
放射線治療
Particle-beam radiation therapy
小線源治療
強度変調放射線治療
Brachytherapy
Intensity-Modulated Radiation Therapy
Stereotactic Radiation Therapy
Stereotactic irradiation
高精度放射線治療
Radiation Oncology
Life Science / Radiological sciences / Radiation oncology
Yokohama City University Graduate School of Medicine, Graduate Professor
日本放射線腫瘍学会 代議員
Committee type:Academic society
日本医学放射線学会関東地方会 世話人
Committee type:Academic society
日本医学放射線学会 代議員
Committee type:Academic society
Journal of Oncology and Cancer Research. Editor.
Committee type:Academic society
横浜放射線医会 理事
Committee type:Academic society
Annals of Radiation Therapy and Oncology. Editor.
Committee type:Academic society
Journal of Cancer and Tumor International. Editor.
Committee type:Academic society
Japanese Journal of Radiology. Editor.
Journal of Radiation Research. Editor.
Committee type:Academic society
横浜放射線治療懇話会 代表世話人
Committee type:Academic society
神奈川県放射線医会 理事
Committee type:Academic society
Long-term outcomes of salvage radiotherapy using TomoTherapy with image-guided radiotherapy for postoperative prostate cancer patients. Reviewed
Mukai Y, Omura M, Minagawa Y, Mase M, Nishikawa Y, Miura I, Hata M
Cancer Diagnosis and Prognosis 5 ( 2 ) 189 - 197 2025.3
Infectious complications in patients receiving superselective intra-arterial chemoradiotherapy for oral squamous cell carcinoma. Reviewed
Kato H, Ohya T, Koizumi T, Iida M, Takano S, Hata M, Nakajima H, Mitsudo K
Oral Diseases in press 2025
Relationship between dose and local control in five-fraction stereotactic body radiotherapy for hepatocellular carcinoma. Reviewed
Nishikawa Y, Ogino I, Mukai Y, Funaoka A, Takeda Y, Hata M
In Vivo in press 2025
Unexpected change in hydrogel spacer volume during external-beam radiation therapy. Reviewed
Ishibashi N, Hata M, Fujikawa A, Mochizuki T, Maebayashi T, Okada M
Japanese Journal of Radiology 42 ( 11 ) 1315 - 1321 2024.11
Identification of factors contributing to testosterone recovery after hormone therapy combined with external radiation therapy for localized prostate cancer. Reviewed
Yokomizo Y, Itoh Y, Kawahara T, Hayashi N, Miyoshi Y, Makiyama K, Hata M, Uemura H
In Vivo 38 ( 4 ) 2074 - 2079 2024.7
Patterns and incidence of pneumonitis and initial treatment outcomes with durvalumab consolidation therapy after radical chemoradiotherapy for stage III non-small cell lung cancer. Reviewed
Sato M, Odagiri K, Tabuchi Y, Okamoto H, Shimokawa T, Nakamura Y, Hata M
Cancers 16 ( 6 ) 1162 2024.3
A unique adverse event of radiotherapy in a patient with IgG4-related disease: a case report. Reviewed
Aimi H, Murai T, Takino K, Naito W, Miura I, Hata M, Inoue T, Omura M
In Vivo 37 ( 6 ) 2840 - 2844 2023.11
Toxic effects of esophageal squamous cell cancer treated with volume modulated arc therapy: preliminary clinical results. Reviewed International journal
Shigenaga D, Ogino I, Watanabe N, Hata M
Anticancer Research : the International Institute of Anticancer Research / IIAR 43 ( 6 ) 2791 - 2798 2023.6
Long-term outcomes of early-stage non-stomach gastrointestinal MALT lymphoma treated with radiation therapy. Reviewed International journal
Ito E, Sugiura M, Watanabe N, Tayama Y, Takano S, Ogino I, Hata M
Anticancer Research : the International Institute of Anticancer Research / IIAR 43 ( 6 ) 2851 - 2857 2023.6
Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas. Reviewed
Chen X, Kioi M, Hayashi Y, Koizumi T, Koike I, Yamanaka S, Hata M, Mitsudo K
Radiation Oncology (London, England) 18 ( 1 ) 90 2023.5
Outcomes of neoadjuvant gemcitabine plus S-1 and radiation therapy for borderline resectable pancreatic cancer. Reviewed
Yabushita Y, Matsuyama R, Miyake K, Homma Y, Kumamoto T, Misumi T, Hata M, Yamanaka S, Fujii S, Endo I
Journal of Hepato-Biliary-Pancreatic Sciences 30 ( 4 ) 493 - 502 2023.4
Prognostic markers including immune and inflammatory factors predict outcomes in patients receiving postoperative radiation therapy for cholangiocarcinoma. Reviewed International journal
Mukai Y, Matsuyama R, Sugiura M, Yabushita Y, Taniuchi R, Homma Y, Hashimoto K, Miyake K, Tabuchi Y, Endo I, Hata M
Asia-Pacific Journal of Clinical Oncology : an official journal of the Chinese Society of Clinical Oncology (CSCO), Clinical Oncology Society of Australia (COSA), Korean Association for Clinical Oncology (KACO), Medical Oncology Group of Australia (MOGA) 19 ( 1 ) 226 - 233 2023.2
Radiation therapy for pelvic recurrent colorectal or gynecological cancer: is whole pelvic irradiation necessary? Reviewed International journal
Ishibashi N, Maebayashi T, Hata M, Aizawa T, Sakaguchi M, Okada M
Annals of Palliative Medicine : an official journal of the Society for Palliative Radiation Oncology 11 ( 6 ) 1855 - 1864 2022.6
Safety and response after peptide receptor radionuclide therapy with 177Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial. Reviewed
Kudo A, Tateishi U, Yoshimura R, Tsuchiya J, Yokoyama K, Takano S, Kobayashi N, Utsunomiya D, Hata M, Ichikawa Y, Tanabe M, Hosono M, Kinuya S
Journal of Hepato-Biliary-Pancreatic Sciences 29 ( 4 ) 487 - 499 2022.4
Sequential chemotherapy after definitive radiotherapy in markedly elderly patients with advanced esophageal cancer. Reviewed
Watanabe S, Ogino I, Kunisaki C, Hata M
Indian Journal of Cancer : an official journal of the Indian Cancer Society 59 ( 2 ) 244 - 250 2022.4
Impact of regional lymph node irradiation on reducing lymph node recurrence in esophageal cancer patients. Reviewed
Watanabe S, Ogino I, Shigenaga D, Hata M
Cancer Diagnosis & Prognosis 2 ( 2 ) 223 - 231 2022.3
Dose to contralateral breast from whole breast irradiation by automated tangential IMRT planning: comparison of flattening-filter and flattening-filter-free modes. Reviewed
Ogino I, Seto H, Shigenaga D, Hata M
Reports of Practical Oncology and Radiotherapy 27 ( 1 ) 113 - 120 2022.3
Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors. Reviewed
Kobayashi N, Takano S, Ito K, Sugiura M, Ogawa M, Takeda Y, Okubo N, Suzuki A, Tokuhisa M, Kaneta T, Utsunomiya D, Hata M, Inoue T, Hosono M, Kinuya S, Ichikawa Y
Annals of Nuclear Medicine 35 ( 12 ) 1332 - 1341 2021.12
Watanabe S, Ogino I, Shigenaga D, Hata M
In Vivo 35 ( 6 ) 3441 - 3448 2021.11
Whole-brain radiation therapy for intracranial metastases as initial or late treatment. Reviewed
Hiranuma H, Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Hata M, Okada M, Gon Y
In Vivo 35 ( 4 ) 2445 - 2450 2021.7
Outcome of radiation therapy for stage IVB uterine cervical cancer with distant lymph nodes metastases; sequential irradiation for distant lymph nodes metastases. Reviewed International journal
Mukai Y, Yokota NR, Sugiura M, Mizushima T, Taniuchi R, Imai Y, Hashimoto K, Tabuchi Y, Miyagi E, Hata M
In Vivo 35 ( 2 ) 1169 - 1176 2021.3
Proton beam therapy for a giant hepatic hemangioma: a case report and literature review. Reviewed
Shimizu S, Mizumoto M, Okumura T, Li Y, Baba K, Murakami M, Ishida T, Nakamura M, Hiroshima Y, Iizumi T, Saito T, Numajiri H, Nakai K, Hata M, Sakurai H
Clinical and Translational Radiation Oncology 3 ( 27 ) 152 - 156 2021.2
Radiotherapy for non-gastric intestinal versus gastric MALT lymphoma: a comparison of treatment outcomes. Reviewed
Watanabe S, Ogino I, Hata M
Blood Research : an official journal of the Korean Society of Hematology 55 ( 4 ) 200 - 205 2020.12
Impact of superselective intra-arterial and systemic chemoradiotherapy for gingival carcinoma; analysis of treatment outcomes and prognostic factors. Reviewed International journal
Mukai Y, Hayashi Y, Koike I, Koizumi T, Sugiura M, Oguri S, Takano S, Kioi M, Sato M, Mitsudo K, Hata M
BMC Cancer 20 ( 1 ) 1154 - 1154 2020.11
Treatment outcome of the combination therapy of high-dose rate intracavitary brachytherapy and intensity-modulated radiation therapy with central-shielding for cervical cancer. Reviewed
Mukai Y, Minagawa Y, Inoue H, Sato A, Matsui K, Fukuda T, Onuma K, Hongo H, Shirata R, Nagata H, Hashimoto H, Inoue T, Hata M, Omura M
In Vivo 34 ( 6 ) 3387 - 3398 2020.11
Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis. Reviewed
Hayashi N, Osaka K, Muraoka K, Hasumi H, Makiyama K, Kondo K, Nakaigawa N, Yao M, Mukai Y, Sugiura M, Takano S, Ito E, Kaizu H, Koike I, Hata M, Taguri M, Miyoshi Y, Izumi K, Kawahara T, Uemura H
World Journal of Urology : an official journal of the Société Internationale d'Urologie 38 ( 10 ) 2477 - 2484 2020.10
The role of palliative radiation therapy in treating pleural or peritoneal disseminated tumors: 22 cases and a review of the literature. Reviewed International journal
Ishibashi N, Maebayashi T, Hata M, Okada M
Annals of Palliative Medicine : an official journal of the Society for Palliative Radiation Oncology (SPRO) 9 ( 5 ) 2586 - 2591 2020.9
Intensity-modulated radiation therapy for lymph node oligo-recurrence. Reviewed
Sato A, Omura M, Minagawa Y, Matsui K, Shirata R, Hongo H, Hashimoto H, Misumi T, Inoue T, Hata M
In Vivo 34 ( 5 ) 2587 - 2593 2020.9
Partial chest wall radiation therapy for positive or close surgical margins after modified radical mastectomy for breast cancer without lymph node metastasis. Reviewed
Ishibashi N, Nishimaki H, Maebayashi T, Adachi K, Sakurai K, Masuda S, Hata M, Okada M
Asia-Pacific Journal of Clinical Oncology : an official journal of the Chinese Society of Clinical Oncology (CSCO), Clinical Oncology Society of Australia (COSA), Korean Association for Clinical Oncology (KACO), Medical Oncology Group of Australia (MOGA) 16 ( 1 ) 28 - 33 2020.2
Outcome of radiation therapy for locally advanced vulvar carcinoma: analysis of inguinal lymph node. Reviewed
Mukai Y, Koike I, Matsunaga T, Yokota NR, Kaizu H, Takano S, Ito E, Sugiura M, Miyagi E, Hata M
In Vivo 34 ( 1 ) 307 - 313 2020.1
National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: the Japanese Radiation Oncology Study Group. Reviewed
Kawaguchi H, Soejima T, Ishibashi N, Akiba T, Hasegawa M, Isobe K, Ito H, Imai M, Ejima Y, Hata M, Sasai K, Shimoda E, Oguchi M, Akimoto T, Japanese Radiation Oncology, Study Group
Journal of Radiation Research 60 ( 5 ) 579 - 585 2019.10
Intensity-modulated radiation therapy using TomoDirect for postoperative radiation of left-sided breast cancer including lymph node area: comparison with TomoHelical and three-dimensional conformal radiation therapy. Reviewed
Takano S, Omura M, Suzuki R, Tayama Y, Matsui K, Hashimoto H, Hongo H, Nagata H, Tanaka K, Hata M, Inoue T
Journal of Radiation Research 60 ( 5 ) 694 - 704 2019.10
Radiation therapy for uterine cervical cancer with lung metastases including oligometastases. Reviewed
Mukai Y, Koike I, Matsunaga T, Yokota NR, Takano S, Sugiura M, Sato M, Miyagi E, Hata M
In Vivo 33 ( 5 ) 1677 - 1684 2019.9
Lymph Node Metastases Diagnosed by 18F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy. Reviewed International journal
Ichiro Ogino, Shigenobu Watanabe, Toshihiro Misumi, Masaharu Hata, Chikara Kunisaki
Anticancer Research : the International Institute of Anticancer Research / IIAR 39 ( 9 ) 4977 - 4985 2019.9
Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liver. Reviewed International journal
Mukai Y, Matsuyama R, Koike I, Kumamoto T, Kaizu H, Homma Y, Takano S, Sawada Y, Sugiura M, Yabushita Y, Ito E, Sato M, Endo I, Hata M
Medicine 98 ( 31 ) e16673 2019.8
Relationship between nutritional status and esophageal fistula formation after radiotherapy for esophageal cancer. Reviewed
Watanabe S, Ogino I, Kunisaki C, Hata M
Cancer Radiothérapie : an official journal of the Société Française de Radiothérapie Oncologique 23 ( 3 ) 222 - 227 2019.6
Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapy. Reviewed International journal
Hayashi Y, Osawa K, Nakakaji R, Minamiyama S, Ohashi N, Ohya T, Iida M, Iwai T, Ozawa T, Oguri S, Koizumi T, Hirota M, Kioi M, Hata M, Mitsudo K
Head & neck 41 ( 6 ) 1777 - 1784 2019.6
Myelosuppression after radiation therapy in patients with or without autologous peripheral blood stem cell transplantation: a retrospective observation study. Reviewed
Ishibashi N, Maebayashi T, Sakaguchi M, Aizawa T, Uchino Y, Hata M, Okada M
Anticancer Research : the International Institute of Anticancer Research / IIAR 39 ( 4 ) 2163 - 2167 2019.4
Radiation therapy for elderly patients with uterine cervical cancer: feasibility of curative treatment. Reviewed
Hata M
International Journal of Gynecological Cancer : an official journal of the International Gynecologic Cancer Society (IGCS) and the European Society of Gynaecological Oncology (ESGO) 29 ( 3 ) 622 - 629 2019.3
Thermochemoradiotherapy using superselective intra-arterial infusion for patients with oral cancer with cervical lymph node metastases. Reviewed International journal
Nozato T, Koizumi T, Hayashi Y, Iida M, Iwai T, Oguri S, Hirota M, Kioi M, Koike I, Hata M, Tohnai I, Mitsudo K
Anticancer research : the International Institute of Anticancer Research / IIAR 39 ( 3 ) 1365 - 1373 2019.3
Is pectus excavatum a risk factor for radiation-induced lung disease in patients undergoing radiation therapy following breast-conserving surgery? Reviewed
Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Hata M, Sakurai K, Okada M
Thoracic Cancer 10 ( 2 ) 203 - 208 2019.2
Changes in the Ki-67 labeling index between primary breast cancer and metachronous metastatic axillary lymph node: a retrospective observational study. Reviewed
Ishibashi N, Nishimaki H, Maebayashi T, Hata M, Adachi K, Sakurai K, Masuda S, Okada M
Thoracic Cancer 10 ( 1 ) 96-102 2019.1
Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report. Reviewed
Kaname Sakuma, Toshiyuki Koizumi, Kenji Mitsudo, Jun Ueda, Yuichiro Hayashi, Toshinori Iwai, Makoto Hirota, Mitomu Kioi, Haruka Yoshii, Hisashi Kaizu, Masaharu Hata, Akira Tanaka, Iwai Tohnai
Oral radiology 35 ( 1 ) 77 - 83 2019.1
Oral cavity cancers treated with superselective intra-arterial chemoradiotherapy with radiation doses less than 60Gy: implications for dose reduction from a propensity score matched analysis. Reviewed
Kaizu H, Hata M, Mitsudo K, Hayashi Y, Ito E, Sugiura M, Takano S, Mukai Y, Koike I, Koizumi T
International Journal of Radiation Research in press 2019
Calcium phosphate cement paste injection as a fiducial marker of cervical cancer. Reviewed
Ogino I, Kitagawa M, Watanabe S, Yoshida H, Hata M
In Vivo : the International Institute of Anticancer Research / IIAR 32 ( 6 ) 1609 - 1615 2018.11
Radio-theranosticsを志向した放射性医薬品開発の現状と展開 Radio-Theranosicsの臨床展開 世界情勢と国内の現状
高野 祥子, 小林 規俊, 市川 靖史, 上村 博司, 中村 元紀, 堀江 慧一, 安田 尚史, 安藤 賢一, 金田 朋洋, 幡多 政治
核医学 55 ( Suppl. ) S120 - S120 2018.11
Acute and late toxicities in localized prostate cancer patients treated with low-dose 125I brachytherapy (110 Gy) in combination with external beam radiation therapy versus brachytherapy alone (160 Gy). Reviewed International journal
Mukai Y, Hayashi N, Koike I, Kaizu H, Takano S, Sugiura M, Ito E, Sato M, Uemura H, Yao M, Hata M
Journal of Contemporary Brachytherapy : an official journal of the Polish Brachytherapy Society and Indian Brachytherapy Society 10 ( 5 ) 397 - 404 2018.10
舌癌に対する逆行性超選択的動注化学放射線療法 118例の治療効果の検討
光藤 健司, 林 雄一郎, 南山 周平, 大橋 伸英, 飯田 昌樹, 岩井 俊憲, 小栗 千里, 小泉 敏之, 來生 知, 廣田 誠, 小池 泉, 幡多 政治, 藤内 祝
日本癌治療学会学術集会抄録集 56回 P63 - 4 2018.10
The importance of concurrent chemotherapy for T1 esophageal cancer: role of FDG-PET/CT for local control. Reviewed
Ogino I, Watanabe S, Hirasawa K, Misumi T, Hata M, Kunisaki C
In Vivo : the International Institute of Anticancer Research / IIAR 32 ( 5 ) 1269 - 1274 2018.9
Analysis of prognostic factors, including the incidence of second primary cancer, in patients with early stage laryngeal squamous cell carcinoma treated by radiation-based therapy
Kaname Sato, Kenichiro Yabuki, Daisuke Sano, Yasuhiro Arai, Yoshihiro Chiba, Teruhiko Tanabe, Goshi Nishimura, Masaharu Hata, Nobuhiko Oridate
Translational Cancer Research 7 ( 4 ) 890 - 900 2018.8
Daily cisplatin and weekly docetaxel versus weekly cisplatin intra-arterial chemoradiotherapy for late T2-3 tongue cancer: a pilot and feasibility trial. Reviewed International journal
Yuichiro Hayashi, Shuhei Minamiyama, Takashi Ohya, Masaki Iida, Toshinori Iwai, Toshiyuki Koizumi, Senri Oguri, Makoto Hirota, Mitomu Kioi, Masaharu Hata, Masataka Taguri, Kenji Mitsudo
Medicina (Kaunas, Lithuania) 54 ( 4 ) 52 2018.7
Treatment outcomes of (chemo)radiotherapy for oropharyngeal cancers: influence of the use of 15 MV X-rays in radiation boost. Reviewed
Kaizu H, Hata M, Takano S, Kasuya T, Nishimura G, Koike I, Taguchi T, Oridate N
International Journal of Radiation Research : the Novin Medical Radiation Institute 16 ( 3 ) 257 - 267 2018.7
National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG). Reviewed
Ishibashi N, Soejima T, Kawaguchi H, Akiba T, Hasegawa M, Isobe K, Ito H, Imai M, Ejima Y, Hata M, Sasai K, Shimoda E, Maebayashi T, Oguchi M, Akimoto T
Journal of Radiation Research 59 ( 4 ) 477 - 483 2018.7
Does protruding type 1 esophageal cancer really have a good response to radiation therapy? – a retrospective observational study. Reviewed
Ishibashi N, Hata M, Maebayashi T, Aizawa T, Sakaguchi M, Okada M
Journal of Thoracic Disease : an official journal of the China State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health (GIRH), First Affiliated Hospital of Guangzhou Medical University, and Society of Translational Medicine 10 ( 6 ) 3512 - 3518 2018.6
Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: Analysis of therapeutic results in 118 cases. Reviewed International journal
Kenji Mitsudo, Yuichiro Hayashi, Shuhei Minamiyama, Nobuhide Ohashi, Masaki Iida, Toshinori Iwai, Senri Oguri, Toshiyuki Koizumi, Mitomu Kioi, Makoto Hirota, Izumi Koike, Masaharu Hata, Iwai Tohnai
Oral oncology 79 71 - 77 2018.4
Radiation therapy for angiosarcoma of the scalp: Total scalp irradiation and local irradiation Reviewed
Masaharu Hata
Anticancer Research 38 ( 3 ) 1247 - 1253 2018.3
Treatment outcome for locally advanced non-small-cell lung cancer using TomoDirect plan and its characteristics compared to the TomoHelical plan Reviewed
Yuki Mukai, Motoko Omura, Harumitu Hashimoto, Kengo Matsui, Hideyuki Hongo, Wataru Yamakabe, Miwa Yoshida, Masaharu Hata, Tomio Inoue
Journal of Medical Radiation Sciences 65 ( 1 ) 55 - 62 2018.3
Radiation therapy for patients with bone metastasis from uterine cervical cancer: Its role and optimal radiation regimen for palliative care Reviewed
Masaharu Hata, Izumi Koike, Etsuko Miyagi, Mikiko Asai-Sato, Hisashi Kaizu, Yuki Mukai, Shoko Takano, Eiko Ito, Madoka Sugiura, Tomio Inoue
Anticancer Research 38 ( 2 ) 1033 - 1040 2018.2
Daily concurrent chemoradiotherapy using retrograde superselective intra-arterial infusion for locally advanced squamous cell carcinoma of the mandibular gingiva Reviewed
Senri Oguri, Kenji Mitsudo, Masaki Iida, Toshinori Iwai, Toshiyuki Koizumi, Makoto Hirota, Mitomu Kioi, Izumi Koike, Masaharu Hata, Iwai Tohnai
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 30 ( 6 ) 483 - 487 2018
Radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma: What is the optimal radiation dose? Reviewed
Hata M
Annals of Radiation Therapy and Oncology 1 ( 3 ) 1012 2017.12
内用療法の普及と安全利用~多職種の立場から~ 新規RI内用療法薬剤の導入と多職種連携 当院の取り組み
高野 祥子, 杉浦 円, 高田 由貴, 有澤 哲, 金田 朋洋, 幡多 政治, 小林 規俊, 市川 靖史, 尾川 松義, 臼井 淳之, 大沼 教子, 立石 由佳, 木藤 理恵, 山中 竹春, 井上 登美夫
核医学 54 ( Suppl. ) S65 - S65 2017.9
内用療法の普及と安全利用 他職種の立場から 新規RI内用療法薬剤の導入と多職種連携 当院の取り組み
高野 祥子, 杉浦 円, 高田 由貴, 有澤 哲, 金田 朋洋, 幡多 政治, 小林 規俊, 市川 靖史, 尾川 松義, 臼井 淳之, 大沼 教子, 立石 由佳, 木藤 理恵, 山中 竹春, 井上 登美夫
核医学技術 37 ( 予稿集 ) 405 - 405 2017.9
Clinical outcomes of retrograde intraarterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years old Reviewed
Yuichiro Hayashi, Kenji Mitsudo, Kaname Sakuma, Masaki Iida, Toshinori Iwai, Hideyuki Nakashima, Yoshiyuki Okamoto, Toshiyuki Koizumi, Senri Oguri, Makoto Hirota, Mitomu Kioi, Izumi Koike, Masaharu Hata, Iwai Tohnai
Radiation Oncology 12 ( 1 ) 112 2017.7
Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer. Reviewed
Yabuki K, Sano D, Shiono O, Arai Y, Chiba Y, Tanabe T, Nishimura G, Takahashi M, Taguchi T, Kaneta T, Hata M, Oridate N
The Laryngoscope : an official journal of the American Laryngological, Rhinological and Otological Society 127 ( 4 ) 862 - 867 2017.4
Radiation Therapy for Very Elderly Patients Aged 80 Years and Older With Squamous Cell Carcinoma of the Uterine Cervix Reviewed
Masaharu Hata, Izumi Koike, Etsuko Miyagi, Reiko Numazaki, Mikiko Asai-Sato, Takeo Kasuya, Hisashi Kaizu, Tonika Matsui, Fumiki Hirahara, Tomio Inoue
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 40 ( 2 ) 178 - 182 2017.4
Radiation therapy for stage IVA uterine cervical cancer: Treatment outcomes including prognostic factors and risk of vesicovaginal and rectovaginal fistulas Reviewed
Masaharu Hata, Izumi Koike, Etsuko Miyagi, Reiko Numazaki, Mikiko Asai-Sato, Hisashi Kaizu, Yuki Mukai, Shoko Takano, Eiko Ito, Madoka Sugiura, Tomio Inoue
Oncotarget 8 ( 68 ) 112855 - 112866 2017
Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapy. Reviewed International journal
Kenichiro Yabuki, Daisuke Sano, Osamu Shiono, Yasuhiro Arai, Hideaki Takahashi, Yoshihiro Chiba, Teruhiko Tanabe, Goshi Nishimura, Masahiro Takahashi, Takahide Taguchi, Tomohiro Kaneta, Masaharu Hata, Nobuhiko Oridate
Head & neck 38 ( 11 ) 1666 - 1671 2016.11
Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature. Reviewed
Ishibashi N, Hata M, Mochizuki T, Ogawa K, Sugiura H, Takekawa Y, Maebayashi T, Aizawa T, Sakaguchi M, Abe O
International Journal of Hematology 104 ( 4 ) 524 2016.10
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma. Reviewed
Nishimura G, Yabuki K, Hata M, Komatsu M, Taguchi T, Takahashi M, Shiono O, Sano D, Arai Y, Takahashi H, Chiba Y, Oridate N
International Journal of Clinical Oncology 21 ( 4 ) 667 2016.8
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma. Reviewed International journal
Goshi Nishimura, Takahide Taguchi, Masahiro Takahashi, Osamu Shiono, Masanori Komatsu, Daisuke Sano, Kenichiro Yabuki, Yasuhiro Arai, Hideaki Takahashi, Masaharu Hata, Nobuhiko Oridate
Cancer chemotherapy and pharmacology 77 ( 6 ) 1315 - 9 2016.6
Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy. Reviewed
Nishimura G, Komatsu M, Hata M, Yabuki K, Taguchi T, Takahashi M, Shiono O, Sano D, Arai Y, Takahashi H, Chiba Y, Oridate N
International Journal of Clinical Oncology 21 ( 2 ) 230 2016.4
Ten-year outcomes of I-125 low-dose-rate brachytherapy for clinically localized prostate cancer: a single-institution experience in Japan Reviewed
Narihiko Hayashi, Koji Izumi, Futoshi Sano, Yasuhide Miyoshi, Hiroji Uemura, Takeo Kasuya, Akiko Mukai, Masayuki Hata, Tomio Inoue
WORLD JOURNAL OF UROLOGY 33 ( 10 ) 1519 - 1526 2015.10
Radiation therapy for para-aortic lymph node metastasis from uterine cervical cancer. Reviewed
Hata M, Miyagi E, Koike I, Numazaki R, Asai-Sato M, Kasuya T, Kaizu H, Mukai Y, Hirahara F, Inoue T
Anticancer Research : the International Institute of Anticancer Research / IIAR 35 ( 9 ) 4849 - 4854 2015.9
Postoperative radiation therapy for extramammary Paget's disease Reviewed
M. Hata, I. Koike, H. Wada, E. Miyagi, T. Kasuya, H. Kaizu, Y. Mukai, T. Inoue
BRITISH JOURNAL OF DERMATOLOGY 172 ( 4 ) 1014 - 1020 2015.4
High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors. Reviewed International journal
Chiyoko Makita, Tatsuya Nakamura, Akinori Takada, Kanako Takayama, Motohisa Suzuki, Yusuke Azami, Takahiro Kato, Iwao Tsukiyama, Masato Hareyama, Yasuhiro Kikuchi, Takashi Daimon, Masaharu Hata, Tomio Inoue, Nobukazu Fuwa
Acta oncologica (Stockholm, Sweden) 54 ( 3 ) 307 - 14 2015.3
Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (< 12 g/dL) and post-radiation therapy F-18 FDG-PET/CT Reviewed
Ryoko Katahira-Suzuki, Masaharu Hata, Ukihide Tateishi, Takahide Taguchi, Shoko Takano, Motoko Omura-Minamisawa, Tomio Inoue
ANNALS OF NUCLEAR MEDICINE 29 ( 1 ) 37 - 45 2015.1
Severe retinopathy following radiation therapy with a moderate dose for orbital mucosa-associated lymphoid tissue lymphoma Reviewed
Masaharu Hata, Akihiro Kaneko, Naoto Tomita, Tomio Inoue
HEMATOLOGICAL ONCOLOGY 32 ( 4 ) 212 - 214 2014.12
Phase II Study of Concurrent Chemoradiotherapy with S-1 in Patients with Stage II (T2N0M0) Squamous Cell Carcinoma of the Pharynx or Larynx Reviewed
Takahide Taguchi, Masahiro Takahashi, Goshi Nishimura, Osamu Shiono, Masanori Komatsu, Daisuke Sano, Yasunori Sakuma, Yuji Tanigaki, Akira Kubota, Masataka Taguri, Masaharu Hata, Nobuhiko Oridate
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 44 ( 12 ) 1158 - 1163 2014.12
咽頭扁平上皮癌の根治的化学放射線治療 治療前Hb値(≧12g/dl)と治療後PET-CTの重要性
鈴木 涼子, 幡多 政治, 立石 宇貴秀, 井上 登美夫, 田口 享秀, 高野 祥子, 大村 素子
核医学 51 ( 4 ) 432 - 432 2014.11
Radiation therapy for angiosarcoma of the scalp Treatment outcomes of total scalp irradiation with X-rays and electrons Reviewed
Masaharu Hata, Hidefumi Wada, Ichiro Ogino, Motoko Omura, Izumi Koike, Yoshibumi Tayama, Kazumasa Odagiri, Takeo Kasuya, Tomio Inoue
STRAHLENTHERAPIE UND ONKOLOGIE 190 ( 10 ) 899 - 904 2014.10
Iris Metastasis from Small-Cell Lung Cancer Reviewed
Masaharu Hata, Tomio Inoue
JOURNAL OF THORACIC ONCOLOGY 9 ( 10 ) 1584 - 1585 2014.10
Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors Reviewed
Kazumasa Odagiri, Motoko Omura, Masaharu Hata, Noriko Aida, Tetsu Niwa, Hiroaki Goto, Susumu Ito, Masanori Adachi, Haruyasu Yoshida, Hiroko Yuki, Tomio Inoue
RADIATION ONCOLOGY 9 ( 1 ) 201 2014.9
Radiation therapy for lymph node metastasis from extramammary Paget's disease Reviewed
M. Hata, I. Koike, H. Wada, Y. Minagawa, T. Kasuya, T. Matsui, R. Suzuki, S. Takano, T. Inoue
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 28 ( 7 ) 873 - 877 2014.7
Relative biological effectiveness of therapeutic proton beams for HSG cells at Japanese proton therapy facilities Reviewed
Mizuho Aoki-Nakano, Yoshiya Furusawa, Akiko Uzawa, Yoshitaka Matsumoto, Ryoichi Hirayama, Chizuru Tsuruoka, Takashi Ogino, Teiji Nishio, Kazufumi Kagawa, Masao Murakami, Go Kagiya, Kyo Kume, Masanori Hatashita, Shigekazu Fukuda, Kazutaka Yamamoto, Hiroshi Fuji, Shigeyuki Murayama, Masaharu Hata, Takeji Sakae, Hideki Matsumoto
JOURNAL OF RADIATION RESEARCH 55 ( 4 ) 812 - 815 2014.7
Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapy Reviewed
Takahide Taguchi, Goshi Nishimura, Masahiro Takahashi, Masanori Komatsu, Daisuke Sano, Naoko Sakuma, Ken-ichiro Yabuki, Yasuhiro Arai, Hideaki Takahashi, Masaharu Hata, Izumi Koike, Nobuhiko Oridate
CANCER CHEMOTHERAPY AND PHARMACOLOGY 73 ( 6 ) 1147 - 1154 2014.6
Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: Analysis of therapeutic results in 112 cases Reviewed
Kenji Mitsudo, Toshiyuki Koizumi, Masaki Iida, Toshinori Iwai, Hideyuki Nakashima, Senri Oguri, Mitomu Kioi, Makoto Hirota, Izumi Koike, Masaharu Hata, Iwai Tohnai
RADIOTHERAPY AND ONCOLOGY 111 ( 2 ) 306 - 310 2014.5
Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy for gingival carcinoma Reviewed
Y. Mukai, M. Hata, K. Mitsudo, I. Koike, T. Koizumi, S. Oguri, M. Kioi, M. Omura, I. Tohnai, T. Inoue
STRAHLENTHERAPIE UND ONKOLOGIE 190 ( 2 ) 181 - 185 2014.2
Malignant melanoma of the lacrimal sac: a case report Reviewed
Jiro Maegawa, Kazunori Yasumura, Toshinori Iwai, Masaharu Hata, Yoshiaki Inayama, Shinji Kobayashi
INTERNATIONAL JOURNAL OF DERMATOLOGY 53 ( 2 ) 243 - 245 2014.2
Radiation therapy for extramammary Paget's disease: treatment outcomes and prognostic factors Reviewed
M. Hata, I. Koike, H. Wada, E. Miyagi, T. Kasuya, H. Kaizu, T. Matsui, Y. Mukai, E. Ito, T. Inoue
ANNALS OF ONCOLOGY 25 ( 1 ) 291 - 297 2014.1
Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma Reviewed
Chiyoko Makita, Tatsuya Nakamura, Akinori Takada, Kanako Takayama, Motohisa Suzuki, Yojiro Ishikawa, Yusuke Azami, Takahiro Kato, Iwao Tsukiyama, Yasuhiro Kikuchi, Masato Hareyama, Masao Murakami, Nobukazu Fuwa, Masaharu Hata, Tomio Inoue
RADIATION ONCOLOGY 9 ( 1 ) 26 2014.1
Small-cell undifferentiated (neuroendocrine) carcinoma of the nasal cavity treated with concurrent chemoradiotherapy including irinotecan and cisplatin. Reviewed
Taguchi T, Isono Y, Sakuma N, Komatsu M, Nishimura G, Takahashi M, Inayama Y, Omura M, Hata M, Oridate N
International Cancer Conference Journal 3 ( 1 ) 11 - 15 2014.1
Chemoradiation as a definitive treatment for cervical lymph node metastases from unknown primary cancer Reviewed
Hisashi Kaizu, Ichiro Ogino, Masaharu Hata, Mari S. Oba, Osamu Shiono, Masanori Komatsu, Tomio Inoue
Anticancer Research 33 ( 11 ) 5187 - 5192 2013.11
Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer Reviewed
Masaharu Hata, Izumi Koike, Etsuko Miyagi, Reiko Numazaki, Mikiko Asai-Sato, Takeo Kasuya, Hisashi Kaizu, Tonika Matsui, Fumiki Hirahara, Tomio Inoue
GYNECOLOGIC ONCOLOGY 131 ( 1 ) 99 - 102 2013.10
Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy Reviewed
Takahide Taguchi, Goshi Nishimura, Masahiro Takahashi, Masanori Komatsu, Daisuke Sano, Naoko Sakuma, Yasuhiro Arai, Yukiko Yamashita, Osamu Shiono, Mariko Hirama, Yasunori Sakuma, Jun-ichi Ishitoya, Masaharu Hata, Ichiro Ogino, Nobuhiko Oridate
CANCER CHEMOTHERAPY AND PHARMACOLOGY 72 ( 4 ) 837 - 843 2013.10
Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer Reviewed
M. Hata, T. Taguchi, I. Koike, G. Nishimura, M. Takahashi, M. Komatsu, D. Sano, K. Odagiri, Y. Minagawa, T. Inoue
STRAHLENTHERAPIE UND ONKOLOGIE 189 ( 1 ) 26 - 32 2013.1
Role of respiratory-gated PET/CT for pancreatic tumors: A preliminary result Reviewed
Takeo Kasuya, Ukihide Tateishi, Kazufumi Suzuki, Hiromitsu Daisaki, Yuji Nishiyama, Masaharu Hata, Tomio Inoue
EUROPEAN JOURNAL OF RADIOLOGY 82 ( 1 ) 69 - 74 2013.1
Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function Reviewed
M. Hata, I. Koike, J. Maegawa, A. Kaneko, K. Odagiri, T. Kasuya, Y. Minagawa, H. Kaizu, Y. Mukai, T. Inoue
STRAHLENTHERAPIE UND ONKOLOGIE 188 ( 12 ) 1102 - 1107 2012.12
Treatment Outcomes, Growth Height, and Neuroendocrine Functions in Patients With Intracranial Germ Cell Tumors Treated With Chemoradiation Therapy Reviewed
Kazumasa Odagiri, Motoko Omura, Masaharu Hata, Noriko Aida, Tetsu Niwa, Ichiro Ogino, Hisato Kigasawa, Susumu Ito, Masataka Adachi, Tomio Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 84 ( 3 ) 632 - 638 2012.11
Definitive radiation therapy for extramammary Paget's disease. Reviewed
Hata M, Koike I, Wada H, Miyagi E, Odagiri K, Minagawa Y, Kasuya T, Kaizu H, Inoue T
Anticancer Research : the International Institute of Anticancer Research / IIAR 32 ( 8 ) 3315 - 3320 2012.8
NONINVASIVE AND CURATIVE RADIATION THERAPY FOR SEBACEOUS CARCINOMA OF THE EYELID Reviewed
Masaharu Hata, Izumi Koike, Motoko Omura, Jiro Maegawa, Ichiro Ogino, Tomio Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 82 ( 2 ) 605 - 611 2012.2
The Role of Radiation Therapy for Uterine Cervical Cancer with Distant Metastasis Reviewed
Masaharu Hata, Motoko Omura, Etsuko Miyagi, Izumi Koike, Reiko Numazaki, Mikiko Asai-Sato, Yoshibumi Tayama, Ichiro Ogino, Fumiki Hirahara, Tomio Inoue
ONCOLOGY 83 ( 2 ) 67 - 74 2012
TREATMENT EFFECTS AND SEQUELAE OF RADIATION THERAPY FOR ORBITAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA Reviewed
Masaharu Hata, Motoko Omura, Izumi Koike, Naoto Tomita, Yasuhito Iijima, Yoshibumi Tayama, Kazumasa Odagiri, Yumiko Minagawa, Ichiro Ogino, Tomio Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81 ( 5 ) 1387 - 1393 2011.12
核医学の進歩と展望 PET導入後の新たな展開 放射線治療への応用
立石 宇貴秀, 幡多 政治, 井上 登美夫
日本医学会総会会誌 28回 ( II ) 91 - 91 2011.10
Assessment of tumor hypoxia by Cu-62-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study Reviewed
Yumiko Minagawa, Kazuya Shizukuishi, Izumi Koike, Choichi Horiuchi, Kei Watanuki, Masaharu Hata, Motoko Omura, Kazumasa Odagiri, Iwai Tohnai, Tomio Inoue, Ukihide Tateishi
ANNALS OF NUCLEAR MEDICINE 25 ( 5 ) 339 - 345 2011.6
ROLE OF RADIOTHERAPY AS CURATIVE TREATMENT OF EXTRAMAMMARY PAGET'S DISEASE Reviewed
Masaharu Hata, Motoko Omura, Izumi Koike, Hidefumi Wada, Etsuko Miyagi, Yoshibumi Tayama, Kazumasa Odagiri, Yumiko Minagawa, Ichiro Ogino, Tomio Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 80 ( 1 ) 47 - 54 2011.5
F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphoma Reviewed
Ryogo Minamimoto, Ukihide Tateishi, Naoto Tomita, Yoshiaki Inayama, Motoko Omura-Minamisawa, Yoshibumi Tayama, Masaharu Hata, Yoshinobu Kubota, Tomio Inoue
ANNALS OF NUCLEAR MEDICINE 24 ( 2 ) 115 - 119 2010.2
Malignant myoepithelioma in the maxillary sinus: case report and review of the literature. Reviewed
Hata M, Tokuuye K, Shioyama Y, Nomoto S, Inadome Y, Fukumitsu N, Nakayama H, Sugahara S, Ohara K, Noguchi M, Akine Y
Anticancer Research : the International Institute of Anticancer Research / IIAR 29 ( 2 ) 497 - 501 2009.2
Proton beam therapy for aged patients with hepatocellular carcinoma. Reviewed
Hata M, Tokuuye K, Sugahara S, Tohno E, Nakayama H, Fukumitsu N, Mizumoto M, Abei M, Shoda J, Minami M, Akine Y
International Journal of Radiation Oncology, Biology, Physics : an official journal of the American Society for Radiation Oncology / ASTRO 69 ( 3 ) 805 - 812 2007.11
Proton beam therapy for aged patients with hepatocellular carcinoma Reviewed
Masaharu Hata, Koichi Tokuuye, Shinji Sugahara, Eriko Tohno, Hidetsugu Nakayama, Nobuyoshi Fukumitsu, Masashi Mizumoto, Masato Abei, Junichi Shoda, Manabu Minami, Yasuyuki Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 69 ( 3 ) 805 - 812 2007.11
Classical tandem-source dwelling covering the entire uterus: Essential in modern intracavitary radiotherapy for cervical cancer? Reviewed
Kiyoshi Ohara, Keiko Nemoto, Kayoko Ohnishi, Takayuki Hashimoto, Nobuyoshi Fukumitsu, Masaharu Hata, Shinji Sugahara, Koichi Tokuuye, Yasuyuki Akine
Radiation Medicine - Medical Imaging and Radiation Oncology 25 ( 8 ) 386 - 392 2007.10
Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites Reviewed
Masaharu Hata, Koichi Tokuuye, Shinji Sugahara, Eriko Tohno, Nobuyoshi Fukumitsu, Takayuki Hashimoto, Kayoko Ohnishi, Keiko Nemoto, Kiyoshi Ohara, Takeji Sakae, Yasuyuki Akine
STRAHLENTHERAPIE UND ONKOLOGIE 183 ( 8 ) 411 - 416 2007.8
Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: Preliminary results of a phase I/II clinical study Reviewed
Masaharu Hata, Koichi Tokuuye, Kenji Kagei, Shinji Sugahara, Hidetsugu Nakayama, Nobuyoshi Fukumitsu, Takayuki Hashimoto, Masashi Mizumoto, Kiyoshi Ohara, Yasuyuki Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 68 ( 3 ) 786 - 793 2007.7
Proton beam therapy for hepatocellular carcinoma with inferior vena cava tumor thrombus: Report of three cases Reviewed
Masashi Mizumoto, Koichi Tokuuye, Shinji Sugahara, Masaharu Hata, Nobuyoshi Fukumitsu, Takayuki Hashimoto, Kayoko Ohnishi, Keiko Nemoto, Kiyoshi Ohara, Yasushi Matsuzaki, Eriko Tohno, Yasuyuki Akine
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 37 ( 6 ) 459 - 462 2007.6
Explanation for the failure of neoadjuvant chemotherapy to improve outcomes after radiotherapy for locally advanced uterine cervical cancer from the standpoint of the tumor regression rate Reviewed
Kiyoshi Ohara, Hajime Tsunoda, Yumiko Oishi Tanaka, Kayoko Ohnishi, Keiko Nemoto, Takayuki Hashimoto, Nobuyoshi Fukumitsu, Masaharu Hata, Shinji Sugahara, Koichi Tokuuye, Hiroyuki Yoshikawa, Yasuyuki Akine
Radiation Medicine - Medical Imaging and Radiation Oncology 25 ( 2 ) 53 - 59 2007.2
Biological intercomparison using gut crypt survivals for proton and carbon-ion beams. Reviewed
Uzawa A, Ando K, Furusawa Y, Kagiya G, Fuji H, Hata M, Sakae T, Terunuma T, Scholz M, Ritter S, Peschke P
Journal of Radiation Research 48 Suppl A A75 - 80 2007
Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis Reviewed
Masaharu Hata, Koichi Tokuuye, Shinji Sugahara, Nobuyoshi Fukumitsu, Takayuki Hashimoto, Kayoko Ohnishi, Keiko Nemoto, Kiyoshi Ohara, Yasushi Matsuzaki, Yasuyuki Akine
STRAHLENTHERAPIE UND ONKOLOGIE 182 ( 12 ) 713 - 720 2006.12
A patient surviving for eight years after proton and x-ray irradiation for advanced esophageal cancer Reviewed
Nobuyoshi Fukumitsu, Koichi Tokuuye, Shinji Sugahara, Takayuki Hashimoto, Masaharu Hata, Kiyoshi Ohara, Takeshi Shibahara, Akira Nakahara, Yasuyuki Akine
ACTA ONCOLOGICA 45 ( 8 ) 1132 - 1134 2006.12
Sequential evaluation of hepatic functional reserve by (99m)Technetium-galactosyl human serum albumin scinitigraphy after proton beam therapy: a report of three cases and a review of the literatures Reviewed
Hiroshi Igaki, Koichi Tokuuye, Tohoru Takeda, Shinji Sugahara, Masaharu Hata, Takayuki Hashimoto, Nobuyoshi Fukumitsu, Jin Wu, Kayoko Ohnishi, Kiyoshi Ohara, Yasuyuki Akine
ACTA ONCOLOGICA 45 ( 8 ) 1102 - 1107 2006.12
Proton beam therapy for hepatocellular carcinoma with limited treatment options Reviewed
Masaharu Hata, Koichi Tokuuye, Shinji Sugahara, Nobuyoshi Fukumitsu, Takayuki Hashimoto, Kayoko Ohnishi, Keiko Nemoto, Kiyoshi Ohara, Yasushi Matsuzaki, Yasuyuki Akine
CANCER 107 ( 3 ) 591 - 598 2006.8
Repeated proton beam therapy for hepatocellular carcinoma Reviewed
T Hashimoto, K Tokuuye, N Fukumitsu, H Igaki, M Hata, K Kagei, S Sugahara, K Ohara, Y Matsuzaki, Y Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 65 ( 1 ) 196 - 202 2006.5
Proton beam therapy for invasive bladder cancer: A prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy Reviewed
M Hata, N Miyanaga, K Tokuuye, Y Saida, K Ohara, S Sugahara, K Kagei, H Igaki, T Hashimoto, K Hattori, T Shimazu, H Akaza, Y Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 64 ( 5 ) 1371 - 1379 2006.4
Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high- and low-response tumors Reviewed
K Ohara, A Oki, YO Tanaka, K Onishi, N Fukumitsu, T Hashimoto, T Satoh, H Tsunoda, M Hata, S Sugahara, K Tokuuye, Y Akine, H Yoshikawa
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 64 ( 4 ) 1179 - 1182 2006.3
Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus Reviewed
M Hata, K Tokuuye, S Sugahara, K Kagei, H Igaki, T Hashimoto, K Ohara, Y Matsuzaki, N Tanaka, Y Akine
CANCER 104 ( 4 ) 794 - 801 2005.8
Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Reviewed
Chiba T, Tokuuye K, Matsuzaki Y, Sugahara S, Chuganji Y, Kagei K, Shoda J, Hata M, Abei M, Igaki H, Tanaka N, Akine Y
Clinical cancer research : an official journal of the American Association for Cancer Research 11 ( 10 ) 3799 - 3805 2005.5
Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: Comparison between chemoradiotherapy and radiotherapy alone Reviewed
Kiyoshi Ohara, Yumiko Oishi Tanaka, Hajime Tsunoda, Akinori Oki, Toyomi Satoh, Kayoko Onishi, Kenji Kagei, Shinji Sugahara, Masaharu Hata, Hiroshi Igaki, Koichi Tokuuye, Yasuyuki Akine, Hiroyuki Yoshikawa
Radiation Medicine - Medical Imaging and Radiation Oncology 23 ( 1 ) 25 - 29 2005.2
Clinical results of proton beam therapy for cancer of the esophagus Reviewed
S Sugahara, K Tokuuye, T Okumura, A Nakahara, Y Saida, K Kagei, K Ohara, M Hata, H Igaki, Y Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 61 ( 1 ) 76 - 84 2005.1
Clinical results of proton beam therapy for skull base chordoma Reviewed
H Igaki, K Tokuuye, T Okumura, S Sugahara, K Kagei, M Hata, K Ohara, T Hashimoto, K Tsuboi, S Takano, A Matsumura, Y Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 60 ( 4 ) 1120 - 1126 2004.11
Initial experience of proton beam therapy at the new facility of the University of Tsukuba Reviewed
Kagei Kenji, Tokuuye Koichi, Sugahara Shinji, Hata Masaharu, Igaki Hiroshi, Hashimoto Takayuki, Ohara Kiyoshi, Akine Yasuyuki
Nippon Acta Radiologica 64 ( 4 ) 225 - 230 2004.5
Proton therapy for head and neck malignancies at Tsukuba Reviewed
K Tokuuye, Y Akine, K Kagei, M Hata, T Hashimoto, T Mizumoto, Y Ohshiro, S Sugahara, K Ohara, T Okumura, J Kusakari, H Yoshida, F Otsuka
STRAHLENTHERAPIE UND ONKOLOGIE 180 ( 2 ) 96 - + 2004.2
Asymptomatic radiation-induced telangiectasia in children after cranial irradiation: Frequency, latency, and dose relation Reviewed
S Koike, N Aida, M Hata, K Fujita, Y Ozawa, T Inoue
RADIOLOGY 230 ( 1 ) 93 - 99 2004.1
Ohara K, Sugahara S, Kagei K, Hata M, Igaki H, Tokuuye K, Akine Y
Radiation Medicine 22 ( 1 ) 42 - 48 2004.1
FDG-PET scanning after radiation can predict tumor regrowth three months later Reviewed
Koike, I, M Ohmura, M Hata, N Takahashi, T Oka, Ogino, I, J Lee, T Umezawa, K Kinbara, K Watai, Y Ozawa, T Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 57 ( 5 ) 1231 - 1238 2003.12
Intramedullary spinal cord germinoma: Case report and review of the literature Reviewed
M Hata, Ogino, I, K Sakata, H Murata, N Kawano, S Matsubara
RADIOLOGY 223 ( 2 ) 379 - 383 2002.5
Radiation therapy for life- or function-threatening infant hemangioma. Reviewed
Ogino I, Torikai K, Kobayasi S, Aida N, Hata M, Kigasawa H
Radiology : an official journal of the Radiological Society of North America / RSNA 218 ( 3 ) 834 - 839 2001.3
Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: Outcomes of late effects on pituitary function and growth in long-term survivors Reviewed
M Hata, Ogino, I, N Aida, K Saito, M Omura, H Kigasawa, Y Toyoda, K Tachibana, S Matsubara, T Inoue
INTERNATIONAL JOURNAL OF CANCER 96 117 - 124 2001
Effects of irradiation on the sensitivity of melatonin release to norepinephrine in cultured pineal bodies of rats Reviewed
K Saito, K Shinohara, M Morofushi, T Funabashi, D Mitsushima, M Hata, S Matsubara, F Kimura
NEUROSCIENCE LETTERS 284 ( 1-2 ) 93 - 96 2000.4
放射線治療計画ガイドライン 2020年版(分担執筆)
幡多 政治
金原出版 2020
Proton Beam Therapy, Encyclopedia of Cancer, 4th Edition.
Hata M
Springer-Verlag Berlin Heidelberg 2017
マイヤース腹部放射線診断学-発生学的・解剖学的アプローチ.
太田 光泰, 幡多 政治
2017
Proton Beam Therapy, Encyclopedia of Cancer, 3rd Edition.
Hata M
Springer-Verlag Berlin Heidelberg 2011
Proton Beam Therapy, Encyclopedia of Cancer, 2nd Edition.
Hata M
Springer-Verlag Berlin Heidelberg 2008
若年女性のホジキンリンパ腫に対して治療計画の工夫により被曝の低減を試みた一例
西川雄太, 荻野伊知朗, 向井佑希, 間瀬美里, 石井好美, 幡多政治
横浜医学 76 ( 1 ) 5 - 10 2025.3
ここまで治る・ここまでわかった非黒色腫皮膚癌(NMSC) 非黒色腫皮膚癌に対する放射線療法
幡多政治
皮膚科 5 ( 6 ) 591 - 596 2024.6
肛門管扁平上皮癌に対する5-FUとMMCを用いた同時化学放射線療法の第II相試験. Editorial
幡多政治
JASTRO Newsletter 151 39 2024.3
子宮頸がんの包括的戦略-ワクチン・検診・診断から最新治療まで- 進行子宮頸がんに対する放射線治療の進歩
幡多政治
産科と婦人科 90 ( 11 ) 1251 - 1256 2023.11
国内新規核医学治療 177Lu-DOTATATEの適応と治療の実際
高野祥子, 小林規俊, 市川靖史, 幡多政治
癌と化学療法 49 ( 8 ) 813 - 820 2022.8
177Lu標識ルテチウムオキソドトレオチドを用いたペプチド受容体核医学治療の空気中の放射能濃度
高野祥子, 尾川松義, 小林規俊, 市川靖史, 細野 眞, 幡多政治
Radioisotopes 71 ( 2 ) 135 - 140 2022.7
177Lu-PSMA核医学治療の現状と課題
高野祥子, 上村博司, 幡多政治
臨床泌尿器科 76 ( 8 ) 772 - 779 2022.7
放射線治療 神経内分泌腫瘍に対する核医学治療
市川靖史, 小林規俊, 徳久元彦, 鈴木章浩, 大久保直紀, 田村繁樹, 竹田雄馬, 高野祥子, 宇都宮大輔, 幡多政治
腫瘍内科 28 ( 5 ) 498 - 504 2021.11
これからの核医学治療 ペプチド受容体放射性核種療法
高野 祥子, 小林 規俊, 尾川 松義, 木藤 理恵, 山城 恒雄, 宇都宮 大輔, 市川 靖史, 幡多 政治
核医学 58 ( Suppl. ) S103 - S103 2021.10
ペプチド受容体放射性核種療法
高野祥子, 小林規俊, 尾川松義, 木藤理恵, 山城恒雄, 宇都宮大輔, 市川靖史, 幡多政治
核医学(Web) 58 ( Supplement ) 2021
18F-FDG-PET/CTを用いた食道癌N1リンパ節転移と放射線治療リンパ節領域範囲
荻野伊知朗, 繁永大輔, 伊藤英子, 渡部成宣, 國崎主税, 幡多政治
臨床放射線 65 ( 11 ) 1207 - 1212 2020.10
定番ブランドのフラッグシップ治療装置が大学病院の高度な放射線治療に求められる効率化、安定稼働、高精度照射を実現する
幡多政治, 野村和人, 瀧下啓介
月刊新医療 47 ( 8 ) 8 - 13 2020.8
Yuichiro Hayashi, Kohei Osawa, Rina Nakakaji, Shuhei Minamiyama, Nobuhide Ohashi, Takashi Ohya, Masaki Iida, Toshinori Iwai, Tomomichi Ozawa, Senri Oguri, Toshiyuki Koizumi, Makoto Hirota, Mitomu Kioi, Masaharu Hata, Kenji Mitsudo
Head and Neck 41 1777 - 1784 2019.6
鼻部に及ぶ進行上顎歯肉癌に対し4経路を用いた逆行性超選択的動注化学放射線療法により原発切除を回避できた1例
小栗 千里, 光藤 健司, 大橋 伸英, 飯田 昌樹, 岩井 俊憲, 小泉 敏之, 廣田 誠, 來生 知, 海津 久, 幡多 政治, 藤内 祝
横浜医学 69 ( 4 ) 543 - 548 2018.10
神経内分泌腫瘍のTheranostics ~Peptide Receptor Radionuclide Therapyの現状と今後の展望~
高野 祥子, 小林 規俊, 金田 朋洋, 幡多 政治, 市川 靖史, 井上 登美夫
臨床核医学 51 ( 3 ) 38 - 42 2018.5
骨髄線維症の脾腫に対する低線量脾照射 重篤な血球減少の回避
幡多 政治, 石橋 直也, 小川 浩司, 赤松 芳行, 望月 隆男
臨床放射線 63 ( 4 ) 481 - 485 2018.4
眼瞼癌の放射線治療 アイシールドによる視機能の温存
幡多 政治, 金子 明博, 小池 泉, 海津 久, 向井 佑希, 高野 祥子, 伊藤 英子, 杉浦 円, 谷内 理紗, 水木 信久, 井上 登美夫
臨床放射線 63 ( 3 ) 329 - 335 2018.3
Radio-Theranosicsの臨床展開-世界情勢と国内の現状-
高野祥子, 小林規俊, 市川靖史, 上村博司, 中村元紀, 堀江慧一, 安田尚史, 伊藤賢一, 金田朋洋, 幡多政治
核医学(Web) 55 ( Supplement ) 2018
頭部血管肉腫の放射線治療 X線と電子線による全頭皮照射
幡多 政治
臨床放射線 62 ( 13 ) 1797 - 1804 2017.12
Safety and Efficacy of Radiation Therapy for Very Elderly Patients Aged 80 Years or Older with Uterine Cervical Cancer
M. Hata, I. Koike, E. Miyagi, R. Numazaki, M. Asai-Sato, H. Kaizu, Y. Mukai, S. Takano, E. Ito, M. Sugiura, T. Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 99 ( 2 ) E294 - E294 2017.10
前立腺癌に対する内分泌併用放射線治療後のテストステロン値に関する検討
横溝 由美子, 上村 博司, 逢坂 公人, 蓮見 壽史, 林 成彦, 槙山 和秀, 近藤 慶一, 中井川 昇, 矢尾 正祐, 幡多 政治
泌尿器外科 30 ( 臨増 ) 929 - 929 2017.5
当院におけるハイリスク前立腺癌に対する内分泌療法併用IMRTの治療成績
横溝 由美子, 上村 博司, 新堀 萌香, 荒木 あずみ, 逢坂 公人, 蓮見 壽史, 林 成彦, 槙山 和秀, 近藤 慶一, 中井川 昇, 矢尾 正祐, 糟谷 健夫, 幡多 政治
日本泌尿器科学会総会 105回 PP19 - 06 2017.4
放射線治療を理解するための基礎 放射線の基礎:核医学分野
小池 泉, 幡多 政治, 井上 登美夫
臨床泌尿器科 70 ( 9 ) 650 - 654 2016.8
最先端の放射線治療
幡多 政治
横浜医学 66 ( 4 ) 577 - 588 2015.10
RADIATION THERAPY FOR PARA-AORTIC LYMPH NODE METASTASIS FROM UTERINE CERVICAL CANCER: OPTIMAL RADIATION DOSE ACCORDING TO METASTATIC LYMPH NODE SIZE
M. Hata, E. Miyagi, I. Koike, R. Numazaki, M. Asai-Sato, T. Kasuya, H. Kaizu, Y. Mukai, E. Ito, M. Sugiura, M. Sato, F. Hirahara, T. Inoue
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 25 ( 9 ) 189 - 189 2015.10
前立腺癌に対する内分泌併用放射線療法後のテストステロン値に関する検討
横溝 由美子, 上村 博司, 河原 崇司, 古屋 一裕, 泉 浩司, 逢坂 公人, 蓮見 壽史, 林 成彦, 槙山 和秀, 中井川 昇, 矢尾 正祐, 幡多 政治, 井上 登美男
日本泌尿器科学会総会 103回 718 - 718 2015.4
Radiation Therapy for Primary Carcinoma of the Eyelid: Tumor Control and Visual Function
M. Hata, I. Koike, J. Maegawa, A. Kaneko, K. Odagiri, T. Kasuya, Y. Minagawa, H. Kaizu, Y. Mukai, T. Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 84 ( 3 ) S513 - S513 2012.11
術前にホルモン療法を施行した密封小線源治療成績についての検討
水野 伸彦, 上村 博司, 林 成彦, 蓼沼 智行, 中村 麻美, 佐野 太, 窪田 吉信, 小田切 一将, 皆川 由美子, 田山 芳史, 幡多 政治, 大村 素子, 井上 登美夫
泌尿器外科 25 ( 8 ) 1629 - 1632 2012.8
前立腺癌 ハイリスク早期癌の治療戦略 ハイリスク早期前立腺癌の治療戦略 IMRTを中心に
林 成彦, 佐野 太, 三好 康秀, 上村 博司, 窪田 吉信, 皆川 由美子, 小田切 将一, 小池 泉, 幡多 政司, 荻野 伊知郎, 井上 登美男
泌尿器外科 25 ( 臨増 ) 963 - 964 2012.5
Genitourinary toxicity after radiotherapy
I. Koike, M. Hata, T. Inoue, M. Omura, H. Uemura, Y. Kubota
Japanese Journal of Clinical Radiology 56 957 - 962 2011.8
【高精度治療および短期照射治療に伴う有害事象】 放射線治療による排尿に関する有害事象 前立腺IMRT施行後2年までの排尿症状変化を中心に
小池 泉, 幡多 政治, 大村 素子, 上村 博司, 窪田 吉信, 井上 登美夫
臨床放射線 56 ( 8 ) 957 - 962 2011.8
The Role of Radiation Therapy for Stage IVB Uterine Cervical Cancer
M. Hata, M. Omura, E. Miyagi, I. Koike, R. Numazaki, M. Asai-Sato, Y. Tayama, I. Ogino, F. Hirahara, T. Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81 ( 2 ) S459 - S459 2011
当院における前立腺癌に対するIMRTの治療経過
河原 崇司, 上村 博司, 幡多 政治, 関口 善吉, 南村 和宏, 伊藤 悠城, 佐野 太, 河路 かおる, 村上 貴之, 槙山 和秀, 中井川 昇, 小川 毅彦, 矢尾 正祐, 寺西 淳一, 皆川 由美子, 小田切 一将, 南澤 素子, 野口 和美, 井上 登美夫, 窪田 吉信
泌尿器外科 23 ( 8 ) 1165 - 1166 2010.8
Endocrinopathies in Intracranial Germ Cell Tumor Patients Treated with Chemoradiation Therapy
K. Odagiri, M. Omura, M. Hata, N. Aida, T. Niwa, S. Ito, H. Kigasawa, M. Adachi, T. Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 78 ( 3 ) S595 - S596 2010
Prediction of Local Control in Head and Neck Cancer using the Maximal Standardized Uptake Value of Cu-62-ATSM
Y. Minagawa, K. Shizukuishi, I. Koike, M. Hata, M. Omura, K. Odagiri, U. Tateishi, T. Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 78 ( 3 ) S435 - S436 2010
Radiation Therapy for Primary Mucosa-associated Lymphoid Tissue (MALT) Lymphoma of the Orbit
M. Hata, I. Ogino, M. Omura, I. Koike, S. Kurihara, Y. Tayama, K. Odagiri, Y. Minagawa, T. Inoue
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75 ( 3 ) S484 - S484 2009
【癌克服の総合戦略 連携科学に基づく多角的アプローチ】 低侵襲かつ高精度を目指す局所療法 粒子線治療
幡多 政治, 井上 登美夫
カレントテラピー 26 ( 5 ) 412 - 416 2008.5
水本斉志, 徳植公一, 林靖孝, 大川綾子, 福光延吉, 中山秀次, 幡多政治, 菅原信二, 大原潔, 秋根康之
日本医学放射線学会学術集会抄録集 66th S217 2007.2
水本斉志, 徳植公一, 大川綾子, 林靖孝, 福光延吉, 幡多政治, 中山秀次, 菅原信二, 大原潔, 秋根康之
日本医学放射線学会学術集会抄録集 66th S216 2007.2
Proton beam therapy for aged patients with hepatocellular carcinoma
M. Hata, K. Tokuuye, S. Sugahara, E. Tohno, H. Nakayama, N. Fukumitsu, M. Abei, J. Shoda, M. Minami, Y. Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 69 ( 3 ) S305 - S305 2007
大川綾子, 徳植公一, 林靖孝, 水本斉志, 福光延吉, 中山秀次, 幡多政治, 菅原信二, 大原潔, 秋根康之
日本放射線腫よう学会誌 18 ( Supplement 1 ) 197 2006.10
大原潔, 水本斉志, 福光延吉, 幡多政治, 菅原信二, 徳植公一, 林靖孝, 大川綾子, 中山秀, 秋根康之
日本放射線腫よう学会誌 18 ( Supplement 1 ) 233 2006.10
林靖孝, 徳植公一, 菅原信二, 幡多政治, 中山秀次, 福光延吉, 水本斉志, 大川綾子, 大原潔, 秋根康之
日本放射線腫よう学会誌 18 ( Supplement 1 ) 139 2006.10
幡多政治, 徳植公一, 菅原信二, 影井兼司, 中山秀次, 福光延吉, 橋本孝之, 水本斉志, 大原潔, 秋根康之
日本放射線腫よう学会誌 18 ( Supplement 1 ) 162 2006.10
Clinical results of proton beam therapy for locoregionally advanced esophageal cancer
S. Sugahara, K. Tokuuye, A. Nakahara, M. Hata, H. Terashima, N. Fukumitsu, T. Shibahara, H. Nakayama, T. Hashimoto, K. Ohara, Y. Akine
RADIOTHERAPY AND ONCOLOGY 81 S358 - S358 2006.10
Conventional source dwelling up to the uterine fundus may not be mandatory in intracavitary radiotherapy for cervical cancer
K. Ohara, K. Ohnishi, K. Nemoto, T. Hashimoto, N. Fukumitsu, M. Hata, S. Sugahara, K. Tokuuye, Y. Akine
RADIOTHERAPY AND ONCOLOGY 81 S254 - S254 2006.10
【前立腺がん放射線療法の進歩】 EBRT+HDRbrachytherapy・重粒子線・陽子線の治療成績 限局性前立腺癌に対する陽子線治療
宮永 直人, 赤座 英之, 及川 剛宏, 関戸 哲利, 樋之津 史郎, 河合 弘二, 島居 徹, 幡多 政治, 徳植 公一, 橋本 孝之, 福光 延吉, 菅原 信二, 秋根 康之
泌尿器外科 19 ( 8 ) 951 - 954 2006.8
子宮頚癌治療におけるネオアジュバント化学療法併用が放射線単独治療に比べ有効でなかった理由
大原潔, 田中優美子, 大西かよ子, 根本景子, 橋本孝之, 福光延吉, 菅原信二, 幡多政治, 徳植公一, 秋根康之
日本医学放射線学会学術集会抄録集 65th S312 2006.2
徳植公一, 橋本孝之, 福光延吉, 幡多政治, 菅原信二, 根本景子, 大西かよ子, 大原潔, 秋根康之
日本医学放射線学会学術集会抄録集 65th S217 2006.2
合併症により治療法が制限された肝細胞癌患者に対する陽子線治療
幡多政治, 徳植公一, 菅原信二, 福光延吉, 橋本孝之, 大西かよ子, 根本景子, 大原潔, 秋根康之
日本医学放射線学会学術集会抄録集 65th S315 2006.2
【消化器がんに対する放射線治療】 消化器がんに対する陽子線治療
秋根 康之, 徳植 公一, 菅原 信二, 幡多 政治, 福光 延吉, 橋本 孝之
臨床消化器内科 21 ( 3 ) 315 - 322 2006.2
Preliminary results of hypofractionated proton beam therapy for hepatocellular carcinoma
N. Fukumitsu, K. Tokuuye, T. Hashimoto, S. Sugahara, M. Hata, K. Ohara, E. Tohno, Y. Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 66 ( 3 ) S279 - S280 2006
Repeated proton beam therapy for previously irradiated hepatocellular carcinoma - Dose-volume histogram (DVH) analysis
T. Hashimoto, K. Tokuuye, K. Ohnishi, N. Fukumitsu, M. Hata, S. Sugahara, K. Ohara, E. Tohno, T. Nishimura, Y. Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 66 ( 3 ) S303 - S303 2006
根本景子, 菅原信二, 徳植公一, 奥村敏之, 影井兼司, 幡多政治, 井垣浩, 大原潔, 橋本孝之, 福光延吉, 秋根康之
茨城県臨床医学雑誌 ( 41 ) 33 2005.12
幡多政治, 徳植公一, 菅原信二, 影井兼司, 福光延吉, 橋本孝之, 大西かよ子, 根本景子, 大原潔, 秋根康之
日本放射線腫よう学会誌 17 ( Supplement 1 ) 106 2005.10
大西かよ子, 幡多政治, 徳植公一, 根本景子, 橋本孝之, 福光延吉, 影井兼司, 菅原信二, 大原潔, 秋根康之
日本放射線腫よう学会誌 17 ( Supplement 1 ) 89 2005.10
橋本孝之, 野間美緒, 徳植公一, 福光延吉, 幡多政治, 影井兼司, 菅原信二, 大原潔, 榊原謙, 秋根康之
日本放射線腫よう学会誌 17 ( Supplement 1 ) 168 2005.10
Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis
M. Hata, K. Tokuuye, S. Sugahara, K. Kagei, N. Fukumitsu, T. Hashimoto, K. Ohnishi, K. Ohara, Y. Matsuzaki, Y. Akine
EJC SUPPLEMENTS 3 ( 2 ) 224 - 225 2005.10
Preliminary results of hypofractionated proton beam therapy for hepatocellular carcinoma
N. Fukumitsu, K. Tokuuye, T. Hashimoto, S. Sugahara, K. Kagei, M. Hata, K. Ohara, Y. Akine
EJC SUPPLEMENTS 3 ( 2 ) 206 - 206 2005.10
Preliminary results of proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus
K. Ohnishi, M. Hata, K. Tokuuye, K. Nemoto, T. Hashimoto, N. Fukumitsu, S. Sugahara, K. Ohara, Y. Matsuzaki, Y. Akine
EJC SUPPLEMENTS 3 ( 2 ) 223 - 223 2005.10
【前立腺癌治療の最近の進歩 とくに放射線療法】 前立腺癌に対する陽子線治療
秋根 康之, 幡多 政治
医学のあゆみ 212 ( 12 ) 1063 - 1067 2005.3
徳植公一, 橋本孝之, 井垣浩, 幡多政治, 影井兼司, 菅原信二, 大城佳子, 福光延吉, 大原潔
日本医学放射線学会学術集会抄録集 64th S160 2005.2
<sup>99m</sup>Tc‐GSAによる肝腫よう陽子線治療後の肝予備能の経時的評価
井垣浩, 徳植公一, 菅原信二, 影井兼司, 幡多政治, 武田徹, 福光延吉, 橋本孝之, 大原潔
日本医学放射線学会学術集会抄録集 64th S180 2005.2
Repeated proton beam therapy for hepatocellular carcinoma
T Hashimoto, K Tokuuye, K Nemoto, K Onishi, N Fukumitsu, H Igaki, M Hata, K Kagei, S Sugahara, K Ohara, Y Matsuzaki, Y Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 63 ( 2 ) S159 - S160 2005
Clinical results of proton beam therapy for esophageal cancer at the University of Tsukuba
S Sugahara, K Tokuuye, A Nakahara, H Igaki, M Hata, K Kagei, H Terashima, T Hashimoto, N Fukumitsu, T Shibahara, K Ohara, Y Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 63 ( 2 ) S163 - S164 2005
【前立腺がんの治療とケアの最前線】 前立腺がんに対する放射線療法
幡多 政治
看護技術 50 ( 14 ) 1248 - 1252 2004.12
肝細胞癌の下大静脈腫瘍栓に対する陽子線治療
水本 斉志, 徳植 公一, 橋本 孝之, 幡多 政治, 影井 兼司, 井垣 浩, 菅原 信二, 大原 潔, 秋根 康之
日本放射線腫瘍学会誌 16 ( Suppl.1 ) 171 - 171 2004.10
Clinical results of proton beam therapy for skull base chordoma
H Iqaki, K Tokuuye, T Okumura, S Sugahara, K Kagei, M Hata, K Ohara, K Tsuboi, T Hashimoto, Y Akine
RADIOTHERAPY AND ONCOLOGY 73 S258 - S258 2004.10
Objective assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging
K Ohara, S Sugahara, K Kagei, M Hata, H Igaki, T Hashimoto, K Tokuuye, Y Akine
RADIOTHERAPY AND ONCOLOGY 73 S291 - S291 2004.10
Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus
M Hata, K Tokuuye, K Ohara, S Sugahara, K Kagei, H Igaki, T Hashimoto, Y Matsuzaki, N Tanaka, Y Akine
RADIOTHERAPY AND ONCOLOGY 73 S318 - S318 2004.10
門脈腫瘍栓をともなう肝細胞癌に対する陽子線治療
幡多 政治, 徳植 公一, 菅原 信二, 影井 兼司, 井垣 浩, 橋本 孝之, 水本 斉志, 大原 潔, 秋根 康之
日本放射線腫瘍学会誌 16 ( Suppl.1 ) 171 - 171 2004.10
肝細胞癌の放射線治療計画における臨床標的体積の治療医間でのばらつきの検討
橋本 孝之, 徳植 公一, 水本 斉志, 井垣 浩, 幡多 政治, 影井 兼司, 菅原 信二, 大原 潔, 秋根 康之
日本放射線腫瘍学会誌 16 ( Suppl.1 ) 171 - 171 2004.10
血清SCC抗原による子宮頸癌の放射線反応評価 MR画像による評価との比較
大原 潔, 橋本 孝之, 影井 兼司, 幡多 政治, 井垣 浩, 菅原 信二, 水本 斉志, 徳植 公一, 秋根 康之
日本放射線腫瘍学会誌 16 ( Suppl.1 ) 180 - 180 2004.10
陽子線,重イオン線治療の基礎と展望
幡多 政治
呼吸 23 ( 10 ) 772 - 777 2004.10
肝細胞癌の陽子線治療における局所制御率の検討
影井 兼司, 徳植 公一, 菅原 信二, 幡多 政治, 井垣 浩, 橋本 孝幸, 水本 斉志, 大原 潔, 秋根 康之
日本放射線腫瘍学会誌 16 ( Suppl.1 ) 94 - 94 2004.10
神経膠腫に対する陽子線治療成績
井垣 浩, 徳植 公一, 坪井 康次, 菅原 信二, 影井 兼司, 幡多 政治, 橋本 孝之, 大原 潔, 秋根 康之
日本放射線腫瘍学会誌 16 ( Suppl.1 ) 128 - 128 2004.10
肝細胞癌に対する陽子線治療後の早期死亡(Early Death after proton beam therapy for hepatocellular carcinoma)
大城 佳子, 井垣 浩, 徳植 公一, 幡多 政治, 影井 兼司, 菅原 信二, 大原 潔, 秋根 康之
日本放射線腫瘍学会誌 16 ( Suppl.1 ) 130 - 130 2004.10
根本 景子, 徳植 公一, 大西 かよ子, 水本 斎志, 橋本 孝之, 井垣 浩, 幡多 政治, 影井 兼司, 菅原 信二, 大原 潔, 秋根 康之
日本放射線腫瘍学会誌 16 ( 3 ) 177 - 182 2004.9
筑波大学陽子線医学研究利用センターにおける新陽子線施設での初期臨床経験
影井 兼司, 徳植 公一, 菅原 信二, 幡多 政治, 井垣 浩, 橋本 孝之, 大原 潔, 秋根 康之
日本医学放射線学会雑誌 64 ( 4 ) 225 - 230 2004.5
子宮頸癌の縮小速度の比較 化学放射線治療vs放射線単独治療
大原 潔, 田中 優美子, 大西 かよ子, 菅原 信二, 影井 兼司, 幡多 政治, 井垣 浩, 徳植 公一, 斎田 幸久, 秋根 康之
日本医学放射線学会雑誌 64 ( 2 ) S214 - S214 2004.2
Accuracy of respiratory-gated proton irradiation for liver tumor
K Kagei, K Tokuuye, S Sugahara, M Hata, H Igaki, Y Tsunashima, T Sakae, K Ohara, Y Akine
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 60 ( 1 ) S428 - S428 2004
筑波大学陽子線医学利用研究センターにおける陽子線治療の臨床試験報告
徳植 公一, 秋根 康之, 塩山 善之, 影井 兼司, 菅原 信二, 井垣 浩, 幡多 政治, 大原 潔, 橋本 孝之
日本放射線腫瘍学会誌 15 ( 4 ) 277 - 283 2003.12
【手術に代わる放射線治療】 浸潤性膀胱癌に対する膀胱温存療法
幡多 政治
映像情報Medical 35 ( 13 ) 1090 - 1095 2003.11
肝細胞癌に対する陽子線治療における肝動脈塞栓療法の有無による治療成績の比較
徳植 公一, 秋根 康之, 菅原 信二, 影井 兼司, 幡多 政治, 井垣 浩, 大原 潔, 根本 景子, 大西 かよ子
日本放射線腫瘍学会誌 15 ( Suppl.1 ) 80 - 80 2003.10
頭蓋底脊索腫に対する陽子線治療成績
井垣 浩, 奥村 敏之, 徳植 公一, 菅原 信二, 影井 兼司, 幡多 政治, 大原 潔, 坪井 康次, 秋根 康之
日本放射線腫瘍学会誌 15 ( Suppl.1 ) 88 - 88 2003.10
子宮頸癌の腫瘍縮小速度の解析 放射線治療単独例と化学療法併用例との比較
大原 潔, 大西 かよ子, 影井 兼司, 菅原 信二, 根本 景子, 幡多 政治, 井垣 浩, 徳植 公一, 秋根 康之
日本放射線腫瘍学会誌 15 ( Suppl.1 ) 142 - 142 2003.10
子宮頸部扁平上皮癌に対する根治照射と術後照射との治療成績の比較
大原 潔, 菅原 信二, 影井 兼司, 徳植 公一, 幡多 政治, 井垣 浩, 秋根 康之
日本癌治療学会誌 38 ( 2 ) 691 - 691 2003.9
Effect of iodine group contrast media on repair process for radiation damages.
MATSUBARA NOBORU, TORIGOE SOICHIRO, KURIHARA HIROAKI, HATADA MASAHARU
Innervision 13 ( 9 ) 49 1998.8
Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus.
Hata M
The 23rd European Society for Therapeutic Radiology and Oncology (ESTRO), Amsterdam 2004.10
Radiation-based cancer imaging and therapy. Current status of charged particle therapy with proton and heavy ion beams.
Hata M
The 5th Four Universities’ Joint Seminar, Tokyo 2008.4
Curative treatment with radiation therapy for extramammary Paget’s disease.
Hata M
The 24th European Society for Therapeutic Radiology and Oncology (ESTRO), Göteborg 2008.9
Radiation therapy for primary mucosa-associated lymphoid tissue (MALT) lymphoma of the orbit.
Hata M
The 51st Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Chicago 2009.11
Treatment outcomes of radiation therapy for primary subglottic cancer.
Hata M
The 29th European Society for Therapeutic Radiology and Oncology (ESTRO), Barcelona 2010.9
The role of radiation therapy for stage IVB uterine cervical cancer.
Hata M
The 53rd Annual Meeting of the American Society for Radiation Oncology (ASTRO), Miami 2011.10
Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function.
Hata M
The 54th Annual Scientific Meeting of the American Society for Radiation Oncology (ASTRO), Boston 2012.10
Radiation therapy for extramammary Paget’s disease: treatment outcomes and prognostic factors.
Hata M
The 55th Annual Scientific Meeting of the American Society for Radiation Oncology (ASTRO), Atlanta 2013.9
Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
Hata M
The 13th European Cancer Conference (ECCO), Paris 2005.10
Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
Hata M
The 43rd Particle Therapy Co-operative Group (PTCOG) meeting, Munich 2005.12
Proton beam therapy for aged patients with hepatocellular carcinoma.
Hata M
The 49th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Los Angeles 2007.10
Radiation therapy for sebaceous carcinoma of the eyelid: tumor control and preservation of visual function. Head and Neck Cancer. Poster Viewing Q&A Session.
Hata M
The 60th Annual Scientific Meeting of the American Society for Radiation Oncology (ASTRO), San Antonio 2018.10
The role and optimal regimen of radiation therapy for patients with bone metastasis from uterine cervical cancer.
Hata M
The 21st European Gynaecological Oncology Congress of the European Society of Gynaecological Oncology (ESGO), Athens 2019.11
Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer.
Hata M
The 33rd European Society for Radiotherapy and Oncology (ESTRO), Vienna 2014.4
Radiation therapy for para-aortic lymph node metastasis from uterine cervical cancer: optimal radiation dose according to metastatic lymph node size.
Hata M
European Society of Gynaecological Oncology (ESGO) 19th International Meeting, Nice 2015.10
Radiation therapy for angiosarcoma of the scalp: total scalp irradiation with X-rays and electrons.
Hata M
The 35th European Society for Radiotherapy and Oncology (ESTRO), Turin 2016.4
Safety and efficacy of radiation therapy for very elderly patients aged 80 years or older with uterine cervical cancer.
Hata M
The 59th Annual Scientific Meeting of the American Society for Radiation Oncology (ASTRO), San Diego 2017.9
Proton therapy for invasive bladder cancer: Treatment results of a bladder-preserving therapy with x-ray irradiation and concurrent intra-arterial chemotherapy followed by proton irradiation boost.
Hata M
The 12th European Cancer Conference (ECCO), Copenhagen 2003.9
Global Peer Review Awards.
2019.9 Publons. Top Peer Reviewer 2019.
Hata M
優秀教育展示賞.
2018.10 日本放射線腫瘍学会第31回学術大会. 眼瞼の脂腺癌に対する放射線治療:腫瘍の制御と視機能の温存.
HATA Masaharu
Peer Review Awards 2018.
2018.9 Publons. The Top Peer Reviewers.
Hata M
注目演題.
2017.11 日本放射線腫瘍学会第30回学術大会. 乳房外Paget病の放射線治療:治療成績と予後因子の解析.
HATA Masaharu
Peer Review Awards 2017.
2017.9 Publons. The Top Peer Reviewers.
Hata M
Top Reviewers Award.
2017.7 American Society for Radiation Oncology (ASTRO). The Outstanding Reviewer of the International Journal of Radiation Oncology, Biology, Physics. [Int J Radiation Oncol Biol Phys 2017;99(1):1-2]
Hata M
ARRO Poster Award.
2013.9 American Society for Radiation Oncology (ASTRO). Radiation therapy for extramammary Paget’s disease: treatment outcomes and prognostic factors.
Hata M
International Poster Award.
2011.10 American Society for Radiation Oncology (ASTRO). The role of radiation therapy for stage IVB uterine cervical cancer.
Hata M
体幹部放射線治療の四次元アルゴリズム解析:呼吸性移動の評価とレベル別対処法の意義
2025 - 2027
文部科学省 科学研究費補助金 基盤研究(C)
HATA Masaharu
Authorship:Principal investigator
悪性腫瘍に対するRI内用療法の現状と課題:普及に向けた取り組みと新規治療法に関する研究
2023
PDRファーマ 医学・薬学に関する研究活動への支援
幡多 政治
悪性腫瘍に対するRI内用療法の現状と課題:普及に向けた取り組みと新規薬剤の開発に関する研究
2022
PDRファーマ 医学・薬学に関する研究活動への支援
HATA Masaharu
Authorship:Principal investigator
合併症を伴うがん患者における至適治療法の解明と治療法の標準化、新規治療法の開発に関する研究
2022
第一三共 奨学寄付プログラム
HATA Masaharu
Authorship:Principal investigator
放射線治療計画における撮像条件が標的描出に与える影響
2022
GEヘルスケアファーマ 奨学寄附プログラム
HATA Masaharu
Authorship:Principal investigator
Clinical use for calcium phosphate cement paste marker in breast cancer and prostate cancer
Grant number:21K07570 2021.4 - 2024.3
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )
AYA(Adolescent & Young Adult,思春期・若年成人)世代のがん治療における至適治療法の解明と治療法の標準化、新規治療法の開発に関する研究
2021
第一三共 奨学寄付プログラム
幡多 政治
Authorship:Principal investigator
Impact of imaging conditions on the target delineation in radiotherapy planning
2021
GE Healthcare Pharma Educational Grant
Hata M
Authorship:Principal investigator
放射線治療計画における撮像条件が標的描出に与える影響
2020
GEヘルスケアファーマ 奨学寄附プログラム
HATA Masaharu
Authorship:Principal investigator
難治性がんに対する治療戦略:集学的治療による至適治療法の解明と標準化、新規治療法の開発に関する研究
2020
第一三共 奨学寄付プログラム
HATA Masaharu
Authorship:Principal investigator
高齢者のがん治療における至適治療法の解明と治療法の標準化、新規治療法の開発に関する研究
2019
第一三共 奨学寄付プログラム
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
希少がんに対する至適治療法の解明と治療法の標準化、新規治療法の開発に関する研究
2018
第一三共 奨学寄付プログラム
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
Research of conservative breast cancer treatment using calcium phosphate cement paste marker
Grant number:17K10487 2017.4 - 2023.3
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )
体幹部放射線治療における呼吸性移動 -四次元アルゴリズム解析と治療法の標準化-
2017 - 2019
文部科学省 科学研究費補助金 基盤研究(C)
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
Molecular biological mechanisms of uterine leiomyoma growth.
Grant number:15K10724 2015.4 - 2018.3
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
SATO Mikiko, HIRAHARA Fumiki, MIYAGI Etsuko, SAKAKIBARA Hideya, NAGASHIMA Yoji, YAMANAKA Shoji, HATA Masaharu
Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )
We have previously implicated erythropoietin (EPO) production in promoting the growth of some leiomyomas. In this study, we proceeded to explore the mechanisms of EPO production in leiomyomas and the role of EPO in leiomyoma growth. Thus, the relationship between EPO mRNA expression and the mutation of MED 12 gene, the major gene reported to be deeply involved in tumorigenesis of leiomyomas, was assessed.
Consequently, we found robust increase of EPO only in MED12 wild type leiomyomas. In addition, estrogen induced EPO mRNA expression in MED12 wild type leiomomas whereas hypoxia did not affect EPO expression with or without the estrogen treatment.
Since EPO expression level was significantly correlated with the tumor size, our study proposed a noble phenotype and mechanisms of leiomyomas to grow large in response to estrogen.
強度変調放射線治療(IMRT)の最適化プログラムの開発
2013
一般財団法人横浜総合医学振興財団 奨励研究助成
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
Molecular biological mechanisms of tumor growth in uterine leiomyoma
Grant number:24592524 2012.4 - 2015.3
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
SATO Mikiko, MIYAGI Yohei, HIRAHARA Fumiki, MIYAGI Etsuko, NAGASHIMA Yoji, YAMANAKA Shoji, HATA Masaharu
Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )
Some uterine leiomyoma stay small, while others may enlarge tremendously. Myomatous erythrocytosis syndrome is a rare complication of uterine leiomyoma caused by erythropoietin (EPO) that is produced by tumor cells. We hypothesize that EPO may act as a factor that stimulates the enlargement of leiomyomas and assessed the EPO expression in leiomyomas and investigated the effects of EPO on the tumor growth.
The mean EPO mRNA expression in the leiomyoma was higher than the corresponding normal myometrium by Real-time RT-PCR. A positive correlation of leiomyoma size and EPO mRNA expression was shown, suggesting the involvement of EPO in leiomyoma growth. Blood vessel maturity was also significantly increased in EPO-producing leiomyomas. As conclusions, EPO is produced in most of conventional leiomyomas and supports a model where EPO accelerates tumor growth, possibly by inducing vessel maturity. Our study suggests one possible mechanism by which some uterine leiomyomas reach a large size.
放射線治療における医療用金属の散乱効果に関する研究
2011
(財)横浜総合医学振興財団 奨励研究助成
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
Quantification of cell-free DNA in the plasma during radiation therapy
Grant number:20591499 2008 - 2010
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
OMURA Motoko, HATA Masaharu, KOIKE Izumi, INOUE Tomio, ICHIKAWA Yasushi, MITUSDOU Kenji, KANG Yun, CHENG Chao, NATSUHORI Masahiro
Grant amount:\3640000 ( Direct Cost: \2800000 、 Indirect Cost:\840000 )
Cell-free plasma DNA is elevated in cancer patients and decreases in response to effective treatments. Consequently, these DNA have potential as new tumor markers. We investigated whether the plasma DNA concentrations in tumor-bearing mice and cancer patients are altered during the course of radiation therapy. The cell-free tumor specific DNA levels in the plasma of those mice were significantly associated with the tumor volume after radiation. The total cell-free plasma DNA levels in cancer patients showed dynamic changes associated with the progression of radiation therapy and decreased at end of the treatment. Additional analysis will be required to elucidate the potential clinical utility of dynamic changes in cell-free plasma DNA during radiation therapy.
体幹部放射線治療における標的の呼吸性移動に関する研究
2008
(財)横浜総合医学振興財団 奨励研究助成
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
放射線治療の照射位置精度向上に関する研究
2007
(財)横浜総合医学振興財団 奨励研究助成
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
中枢神経系悪性腫瘍に対する放射線治療の基礎的研究
2004 - 2005
文部科学省 科学研究費補助金 若手研究(B)
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
メラトニンを用いた放射線照射が腫瘍細胞のアポトーシスとフリーラジカルに与える影響
2002 - 2003
文部科学省 科学研究費補助金 若手研究(B)
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
時間生物学的放射線治療法の確立
1999
文部省 科学研究費補助金 萌芽的研究
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
放射線照射のグリア細胞機能への影響
1997
文部省 科学研究費補助金 萌芽的研究
HATA Masaharu
Authorship:Principal investigator Grant type:Competitive
The Effet of lodine-Based Contrast Agent on the Process of Radiation-Induced Damage Repair
Grant number:08671045 1996 - 1998
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
MATSUBARA Sho, HATA Masaharu, TORIGOE Soichiro
Grant amount:\800000 ( Direct Cost: \800000 )
We analysed chromosomal aberrations in the peripheral blood after administration of contrast agents and gamma ray irradiation. Increased dicentric or ring chromosome formation was observed when adding contrast agents (3SOmOsm/Kg H_2O) within 15 min after gamma ray irradiation. When adding 60 min after irradiation, however, the rate of chromosomal aberrations markedly decreased, probably beacuse the process of chromosomal repair had been completed.
Regarding molecular biological analysis we examined the phosphorylation or protein level of SAPK/JNK and GADD45 using confluent HeLa cells. Ten Gy of gamma ray irradiation with contrast agents upregulated GADD45 protein, but caused little change in SAPK/ JNK phosphorylation or protein level.